The Clinical Trials Directive, which came into force in May 2004 in order to create a harmonised framework for clinical drug research across Europe, is still hampering such research, according to new findings presented at the European Cancer Conference.
The European Commission has approved Exelon® patch (rivastigmine transdermal patch), an innovative way to deliver this effective medicine to patients suffering from mild to moderately severe Alzheimer’s disease.
An under-used colon cancer screening test now available in the U.S. effectively detects colorectal cancer and may help to improve colon cancer screening rates, according to investigators at the Kaiser Permanente Division of Research. The study appears in the September 25, 2007 issue of the Journal of the National Cancer Institute (JNCI).
The Georgia Institute of Technology and Emory University have received a$1.5 million grant from the National Science Foundation to establish “The Origins Project,” a center for integrated research, education and public outreach focused on the chemistry that may have led to the origin of life.
A new book of pocket-charts that will help health workers to identify people at risk of heart attacks and strokes and save lives by prescribing the most appropriate treatment is published by the World Health Organization (WHO).
On 23 August 2007, Dr Howard Zucker, Head of the WHO cluster Health Technology and Pharmaceuticals and Representative of the Director-General on Intellectual Property, Innovation and Public Health of the World Health Organization (WHO), was visiting the Paul-Ehrlich-Institut (PEI) at Langen near Frankfurt am Main, Germany.
Daily injections could be a thing of the past for people with diabetes thanks to an innovative new product supported by the Australian government.
An innovative Hobart company has developed a system for hospitals and clinics which will prove invaluable in the management of chronic diseases.
The Province has allocated the $100-million Health Innovation Fund to British Columbia?s six health authorities, announced Health Minister George Abbott today.
The University of Illinois at Chicago College of Pharmacy has received a grant from the U.S. Department of Defense to develop new drugs to combat agents of bioterrorism.